-
1دورية أكاديمية
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi Hastanesi/İç Hastalıkları Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Genetik Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji Anabilim Dalı., Ali, Rıdvan, Özkalemkaş, Fahir, Özkocaman, Vildan, Yakut, Tahsin, Nazlıoğlu, Hülya Öztürk, Budak, Ferah Ah, Pekgöz, Murat, Korkmaz, Serhat, Karkucak, Mutlu, Özçelik, Tülay, Tunalı, Ahmet, F-4657-2014, AAH-1854-2021, AAG-8495-2021, 7201813027, 6601912387, 6603145040, 6602802424, 57197115377, 6701913697, 36010142900, 36009787600, 35388323500, 7005424333, 6602797853
مصطلحات موضوعية: Oncology, Blastic crisis, Chronic myeloid leukemia, Cytogenetic response, Imatinib, Chronic myelogenous leukemia, Bone-marrow fibrosis, Mesylate therapy, Myelocytic-leukemia, Chronic-phasebcr-abl, Transformation, Progression, Resistance, Options, Adult, Antineoplastic agents, Blast crisis, Chromosome aberrations, Cytogenetic analysis, Humans, In situ hybridization, fluorescence, Leukemia, myelogenous, chronic, BCR-ABL positive, Male, Piperazines, Pyrimidines, Protein Tyrosine Kinase Inhibitor
العلاقة: Makale - Uluslararası Hakemli Dergi; International Journal of Clinical Oncology; Ali, R. vd. (2009). "Sudden blastic crisis and additional chromosomal abnormalities during chronic myeloid leukemia in the imatinib era". International Journal of Clinical Oncology, 14(6), 545-550.; https://doi.org/10.1007/s10147-009-0884-5Test; https://link.springer.com/article/10.1007/s10147-009-0884-5Test; http://hdl.handle.net/11452/26745Test; 000272463700014; 2-s2.0-72949090889; 545; 550; 14
-
2
المؤلفون: Fahir Özkalemkaş, Rıdvan Ali, Mutlu Karkucak, Murat Pekgöz, Hulya Ozturk Nazlioglu, Serhat Korkmaz, Tahsin Yakut, Ahmet Tunali, Ferah Budak, Vildan Ozkocaman, Tulay Ozcelik
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi Hastanesi/İç Hastalıkları Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Genetik Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji Anabilim Dalı., Ali, Rıdvan, Özkalemkaş, Fahir, Özkocaman, Vildan, Yakut, Tahsin, Nazlıoğlu, Hülya Öztürk, Budak, Ferah Ah, Pekgöz, Murat, Korkmaz, Serhat, Karkucak, Mutlu, Özçelik, Tülay, Tunalı, Ahmet, F-4657-2014, AAH-1854-2021, AAG-8495-2021
مصطلحات موضوعية: Male, Pathology, Bone marrow cell, Leukocytosis, CD33, Treatment response, Piperazines, Acute kidney failure, Antineoplastic agents, Medicine, Cell structure, Pallor, CD34 antigen, In situ hybridization, fluorescence, Chronic myeloid leukemia, Glycophorin A, Chromosome 19, General Medicine, Prognosis, Chromosome 13, Chronic Myeloid Leukemia, Imatinib, Protein Tyrosine Kinase Inhibitor, Chromosome 21, Oncology, Microsomal aminopeptidase, Imatinib Mesylate, Mesylate therapy, Human, medicine.medical_specialty, Article, Treatment duration, Transformation, Cytogenetics, Blastic crisis, Case report, Myelocytic-leukemia, Humans, Blast cell, Purpura, CD19 antigen, CD33 antigen, CD45 antigen, medicine.disease, Dyspnea, Karyotyping, Splenomegaly, Blast crisis, Surgery, Disseminated intravascular clotting, Fluorescence in situ hybridization, Continuous infusion, Myeloid, Blast cell crisis, Resistance, Myelofibrosis, Bone marrow biopsy, BCR ABL protein, hemic and lymphatic diseases, Flow cytometry, Fatigue, Priority journal, Staining, CD61 antigen, medicine.diagnostic_test, Progression, Cytarabine, Myeloid leukemia, Anemia, Hematology, Cytogenetic analysis, Death, Leukemia, Reticulin, medicine.anatomical_structure, Benzamides, Fibrinogen receptor, Chronic-phasebcr-abl, Leukemia, myelogenous, chronic, BCR-ABL positive, medicine.symptom, Chromosome aberration, Drug dose increase, Chronic myelogenous leukemia, medicine.drug, Adult, Options, Bone-marrow fibrosis, Chromosome aberrations, Leukapheresis, Human tissue, Tumor lysis syndrome, Chromosome 8, business.industry, Daunorubicin, Philadelphia 1 chromosome, Thrombocytopenia, Pyrimidines, Leukocyte count, Cell infiltration, Bone marrow, Cytogenetic response, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91eea59e5b394d8c7d6463fb7766132eTest
http://hdl.handle.net/11452/26745Test